The National Agency for Food and Drugs Administration and Control (NAFDAC) has raised the alarm over the circulation of suspected counterfeit Augmentin 625 milligram Tabs in the country.

According to NAFDAC, the product fell short of the labeling requirements.

The alert signed by the management of NAFDAC and titled ‘NAFDAC Alert And Sensitization Of The Public On Suspected Falsified Augmentin 625mg’ was obtained from the agency’s website.

NAFDAC said the suspected falsified Augmentin which was manufactured in April 2021 would expire on April 2024.

It also noted that the batch number of the falsified drug is 562626 with a NAFDAC registration number- 04-1928.